drugset / Trial / NCT00026468
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
RandomizedSingle-groupDouble-blindPrevention
Summary
RATIONALE: Exisulind may be effective in preventing the development and growth of polyps in patients who have familial adenomatous polyposis. PURPOSE: Randomized phase II/III trial to determine the effectiveness of exisulind in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
Timeline
- Start
- 1999-07
- Primary completion
- 1999-07
- Completion
- 1999-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exisulind | Small molecule | — | Oral |